Advances Amgen’s Leadership in CD19 Directed, B-Cell Depletion Therapies for Serious Autoimmune Diseases Including NMOSD, IgG4-RD and gMG THOUSAND OAKS, CA, USA I April 3, 2025 I Amgen (NASDAQ:AMGN) ...
Philanthropist John Spiers said he believes that passing his shares to a foundation may no longer be the right path for the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback